Literature DB >> 11933726

Using an artificial neural network to predict healing times and risk factors for venous leg ulcers.

R J Taylor1, A D Taylor, J V Smyth.   

Abstract

OBJECTIVES: This study aimed to identify the risk factors that influence the healing process of venous leg ulcers treated with compression bandaging, with a view to predicting healing time.
METHOD: A retrospective cohort study was performed on data collected prospectively on 325 consecutive patients presenting with 345 venous ulcers at the Salford Primary Care Trust leg ulcer clinic between January 1997 and December 1999. Use of an artificial neural network (ANN) technique accurately predicted the healing times for 68% of the patients.
RESULTS: The ANN demonstrated that healing was significantly related to a history of previous leg ulceration, 'quite wet' ulcer exudate, high body mass index, large initial total ulcer area, increasing age and male gender.
CONCLUSION: The ability to identify at presentation ulcers that might be resistant to standard therapy would allow early consideration of more radical treatments such as hospitalisation, wound debridement or venous surgery.

Entities:  

Mesh:

Year:  2002        PMID: 11933726     DOI: 10.12968/jowc.2002.11.3.26381

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  15 in total

1.  Delayed cutaneous wound healing in aged rats compared to younger ones.

Authors:  Onur C Soybir; Sibel Ö Gürdal; Ebru Ş Oran; Feti Tülübaş; Meral Yüksel; Ayşenur İ Akyıldız; Ayhan Bilir; Gürsel R Soybir
Journal:  Int Wound J       Date:  2011-12-01       Impact factor: 3.315

Review 2.  Prediction and monitoring the therapeutic response of chronic dermal wounds.

Authors:  Keith Moore; Roisin McCallion; Richard J Searle; Michael C Stacey; Keith G Harding
Journal:  Int Wound J       Date:  2006-06       Impact factor: 3.315

3.  Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression.

Authors:  Jiann-Jyh Lai; Kuo-Pao Lai; Kuang-Hsiang Chuang; Philip Chang; I-Chen Yu; Wen-Jye Lin; Chawnshang Chang
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

4.  Mice with a targeted mutation of patched2 are viable but develop alopecia and epidermal hyperplasia.

Authors:  Erica Nieuwenhuis; Jun Motoyama; Paul C Barnfield; Yoshiaki Yoshikawa; Xiaoyun Zhang; Rong Mo; Michael A Crackower; Chi-Chung Hui
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Predicting delayed healing: The diagnostic accuracy of a venous leg ulcer risk assessment tool.

Authors:  Helen E Edwards; Christina N Parker; Charne Miller; Michelle Gibb; Suzanne Kapp; Rajna Ogrin; Jacinta Anderson; Kerrie Coleman; Dianne Smith; Kathleen J Finlayson
Journal:  Int Wound J       Date:  2017-12-26       Impact factor: 3.315

6.  Androgen receptor-mediated inhibition of cutaneous wound healing.

Authors:  Gillian S Ashcroft; Stuart J Mills
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  The Wound Healing Index for Predicting Venous Leg Ulcer Outcome.

Authors:  Caroline E Fife; Susan D Horn
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-12-18       Impact factor: 4.730

8.  Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly.

Authors:  Matthew J Hardman; Gillian S Ashcroft
Journal:  Genome Biol       Date:  2008-05-13       Impact factor: 13.583

9.  Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia.

Authors:  B Asling; J Jirholt; P Hammond; M Knutsson; A Walentinsson; G Davidson; L Agreus; A Lehmann; M Lagerström-Fermer
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

10.  The effectiveness of vacuum-assisted closure therapy in patients with infected venous leg ulcers.

Authors:  Esra Ertürk Tekin; Mehmet Ali Yeşiltaş; Ayhan Uysal; İsmail Haberal
Journal:  Cardiovasc J Afr       Date:  2021-07-26       Impact factor: 0.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.